We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
SVF Investment Corporation | NASDAQ:SVFAU | NASDAQ | Trust |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-39862 |
98-1561624 | ||
(State or other jurisdiction of |
(Commission |
(IRS Employer | ||
incorporation or organization) |
File Number) |
Identification No.) |
1 Circle Star Way |
||||
San Carlos, California |
94070 | |||
(Address Of Principal Executive Offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol: |
Name of Each Exchange on Which Registered: | ||
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-fifth of one redeemable warrant |
SVFAU |
Nasdaq Capital Market | ||
Class A Ordinary Shares included as part of the units |
SVFA |
Nasdaq Capital Market | ||
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 |
SVFAW |
Nasdaq Capital Market |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
March 31, 2021 |
December 31, 2020 |
|||||||
(Unaudited) (Restated) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | 705,604 | $ | — | ||||
Due from underwriters |
600,000 | — | ||||||
Due from related party |
30,452 | — | ||||||
Prepaid expenses |
2,111,663 | 12,945 | ||||||
|
|
|
|
|||||
Total current assets |
3,447,719 | 12,945 | ||||||
Investments held in Trust Account |
603,757,865 | — | ||||||
Deferred offering costs associated with the initial public offering |
— | 605,335 | ||||||
|
|
|
|
|||||
Total Assets |
$ |
607,205,584 |
$ |
618,280 |
||||
|
|
|
|
|||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: |
|
|||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 72,750 | $ | 353,332 | ||||
Accrued expenses |
383,488 | 197,236 | ||||||
Working capital loan - related party |
4,256,980 | — |
||||||
Note payable - related party |
— | 172,732 | ||||||
|
|
|
|
|||||
Total current liabilities |
4,713,218 | 723,300 | ||||||
Deferred underwriting commissions |
21,131,250 | — | ||||||
Derivative liabilities |
68,238,700 | — | ||||||
|
|
|
|
|||||
Total Liabilities |
94,083,168 | 723,300 | ||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 60,375,000 and 0 shares at redemption value of $10.00 per share as of March 31, 2021 and December 31, 2020, respectively |
603,750,000 | — | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of March 31, 2021 and December 31, 2020 |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized (excluding 60,375,000 shares subject to possible redemption) |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 15,093,750 shares issued and outstanding as of March 31, 2021 and December 31, 2020 |
1,509 | 1,509 | ||||||
Additional paid-in capital |
— | 23,491 | ||||||
Accumulated deficit |
(90,629,093 | ) | (130,020 | ) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
(90,627,584 | ) | (105,020 | ) | ||||
|
|
|
|
|||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ |
607,205,584 |
$ |
618,280 |
||||
|
|
|
|
General and administrative expenses |
$ | 766,717 | ||
General and administrative expenses - related party |
28,076,170 | |||
|
|
|||
Loss from operations |
$ | (28,842,887 | ) | |
Other income (expenses): |
||||
Offering costs associated with derivative warrant liabilities |
(2,567,170 | ) | ||
Loss on the forward purchase agreement |
(97,422,680 | ) | ||
Loss on working capital loan |
(2,256,980 | ) | ||
Change in fair value of derivative liabilities |
116,234,150 | |||
Income from investments held in Trust Account |
7,865 | |||
|
|
|||
Net loss |
$ | (14,847,702 | ) | |
|
|
|||
Basic and diluted weighted average shares outstanding of Class A ordinary shares |
52,995,833 | |||
|
|
|||
Basic and diluted net loss per ordinary share, Class A ordinary shares |
(0.22 | ) | ||
Basic and diluted weighted average shares outstanding of Class B ordinary shares |
14,853,125 | |||
Basic and diluted net loss per ordinary share, Class B ordinary shares |
$ | (0.22 | ) | |
|
|
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2020 |
— |
$ |
— |
15,093,750 |
$ |
1,509 |
$ |
23,491 |
$ |
(130,020 |
) |
$ |
(105,020 |
) | ||||||||||||||
Accretion of Class A ordinary shares subject to redemption |
— | — | — | — | (23,491 | ) | (75,651,371 | ) | (75,674,862 | ) | ||||||||||||||||||
Net loss |
— | — | — | — | — | (14,847,702 | ) | (14,847,702 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited) |
— |
$ |
— |
15,093,750 |
$ |
1,509 |
$ |
— |
$ |
(90,629,093 |
) |
$ |
(90,627,584 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
||||
Net loss |
$ | (14,847,702 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
General and administrative expenses paid by related party under promissory note |
60,201 | |||
Non-cash compensation to Sponsor |
28,056,170 | |||
Offering costs associated with derivative warrant liabilities |
2,567,170 | |||
Loss on the forward purchase agreement |
97,422,680 | |||
Loss on working capital loan |
2,256,980 | |||
Change in fair value of derivative liabilities |
(116,234,150 | ) | ||
Income from investments held in Trust Account |
(7,865 | ) | ||
Changes in operating assets and liabilities: |
||||
Due from related party |
(30,452 | ) | ||
Prepaid expenses |
(2,098,718 | ) | ||
Accounts payable |
(297,887 | ) | ||
Accrued expenses |
262,424 | |||
|
|
|||
Net cash used in operating activities |
(2,891,149 | ) | ||
|
|
|||
Cash Flows from Investing Activities: |
||||
Cash deposited in Trust Account |
(603,750,000 | ) | ||
|
|
|||
Net cash used in investing activities |
(603,750,000 | ) | ||
|
|
|||
Cash Flows from Financing Activities: |
||||
Proceeds received from working capital loan to related party |
2,000,000 | |||
Repayment of note payable to related party |
(295,732 | ) | ||
Proceeds received from initial public offering, gross |
603,750,000 | |||
Proceeds received from private placement |
14,075,000 | |||
Offering costs paid |
(12,182,515 | ) | ||
|
|
|||
Net cash provided by financing activities |
607,346,753 | |||
|
|
|||
Net increase in cash |
705,604 | |||
Cash - beginning of the period |
— | |||
|
|
|||
Cash - end of the period |
$ |
705,604 |
||
|
|
|||
Supplemental disclosure of noncash investing and financing activities: |
||||
Offering costs included in accounts payable |
$ | 17,305 | ||
Offering costs included in accrued expenses |
$ | 75,000 | ||
Offering costs paid by related party under promissory note |
$ | 62,800 | ||
Reversal of accrued expenses |
$ | (151,172 | ) | |
Deferred underwriting commissions |
$ | 21,131,250 | ||
Due from underwriters - offering costs |
$ | 600,000 |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended March 31, 2021 |
||||||||
Class A ordinary shares |
Class B ordinary shares |
|||||||
Basic and diluted net loss per ordinary share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ | (11,597,324 | ) | $ | (3,250,378 | ) | ||
Denominator: |
||||||||
Basic and diluted weighted average ordinary shares outstanding |
52,995,833 | 14,853,125 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per ordinary share |
$ | (0.22 | ) | $ | (0.22 | ) | ||
|
|
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; and |
• | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Gross proceeds |
$ |
603,750,000 |
||
Less: |
||||
Proceeds allocated to public warrants |
(44,919,000 |
) | ||
Class A ordinary shares issuance costs |
(30,755,862 |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
75,674,862 |
|||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ |
603,750,000 |
||
|
|
Fair Value Measured as of March 31, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account |
$ | 603,757,865 | $ | — | $ | — | $ | 603,757,865 | ||||||||
Liabilities: |
||||||||||||||||
Working capital loan – related party |
$ | — | $ | — | $ | 4,256,980 | $ | 4,256,980 | ||||||||
Derivative liabilities - public warrants |
$ | 24,995,250 | $ | — | $ | — | $ | 24,995,250 | ||||||||
Derivative liabilities - private warrants |
$ | — | $ | — | $ | 22,332,330 | $ | 22,332,330 | ||||||||
Derivative liabilities - forward purchase warrants |
$ | — | $ | — | $ | 20,911,120 | $ | 20,911,120 |
As of January 12, 2021 |
As of March 31, 2021 |
|||||||
Option term (in years) |
1.4 -5 | 1.2 -5 |
||||||
Volatility |
20.00 | % | 10.00 | % | ||||
Risk-free interest rate |
0.73 | % | 1.21 | % | ||||
Expected dividends |
0.00 | % | 0.00 | % |
Derivative liabilities beginning of the period |
$ | — | ||
Issuance of derivative liabilities (1) |
184,472,850 | |||
Change in fair value of derivative liabilities (2) |
(116,234,150 | ) | ||
|
|
|||
Derivative liabilities at March 31, 2021 |
$ | 68,238,700 | ||
|
|
(1) |
includes a balance of $97.4 million from the forward purchase agreement , and a balance of $87.0 million from public warrants and private placement warrants. |
(2) |
includes a $76.5 million gain from the change in fair value from the forward purchase agreement, and $39.7 million gain from the change in fair value from Public Warrants and Private Placement Warrants. |
As of March 31, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
607,205,584 |
$ |
— |
$ |
607,205,584 |
||||||
Working capital loan - related party |
2,000,000 | 2,256,980 | 4,256,980 | |||||||||
Total current liabilities |
2,456,238 |
2,256,980 |
4,713,218 |
|||||||||
Total liabilities |
91,826,188 |
2,256,980 |
94,083,168 |
|||||||||
Class A ordinary shares subject to possible redemption |
510,379,390 | 93,370,610 | 603,750,000 | |||||||||
Preference shares |
— | — | — | |||||||||
Class A ordinary shares |
934 | (934 | ) | — | ||||||||
Class B ordinary shares |
1,509 | — | 1,509 | |||||||||
Additional paid-in capital |
17,718,305 | (17,718,305 | ) | — | ||||||||
Accumulated deficit |
(12,720,742 | ) | (77,908,351 | ) | (90,629,093 | ) | ||||||
Total shareholders’ equity (deficit) |
5,000,006 |
(95,627,590 |
) |
(90,627,584 |
) | |||||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
607,205,584 |
$ | — | $ |
607,205,584 |
Statement of Shareholders’ Equity (Deficit) as of March 31, 2021 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Sale of Class A ordinary shares in initial public offering, gross |
$ | 558,831,000 | $ | (558,831,000 | ) | $ | — | |||||
Offering costs |
$ | (30,755,862 | ) | $ | 30,755,862 | $ | — | |||||
Shares subject to possible redemption |
$ | (510,379,390 | ) | $ | 510,379,390 | $ | — | |||||
Net loss |
$ | (12,590,722 | ) | $ | (2,256,980 | ) | $ | (14,847,702 | ) | |||
Accretion of Class A ordinary shares subject to redemption |
$ | — | $ | (75,674,862 | ) | $ | (75,674,862 | ) | ||||
Total shareholders’ equity (deficit) |
$ | 5,000,006 | $ | (95,627,590 | ) | $ | (90,627,584 | ) |
For the Three Months Ended March 31, 2021 |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Cash Flows from Operating Activities: |
||||||||||||
Net loss |
$ |
(12,590,722 |
) |
$ |
(2,256,980 |
) |
$ |
(14,847,702 |
) | |||
Loss on working capital loan |
$ |
— |
$ |
2,256,980 |
$ |
2,256,980 |
||||||
Supplemental Disclosure of Noncash Financing Activities: |
||||||||||||
Initial value of Class A ordinary shares subject to possible redemption |
$ | (394,350,610 | ) | $ | 394,350,610 | $ | — | |||||
Change in value of Class A ordinary shares subject to possible redemption |
$ | (116,028,780 | ) | $ | 116,028,780 | $ | — |
For the three months ended March 31, 2021 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
% Change |
||||||||||||
Other income (expenses): |
||||||||||||||||
Loss on working capital loan |
— |
(2,256,980 |
) |
(2,256,980 |
) |
100.0 |
% | |||||||||
Net loss |
(12,590,722 |
) |
(2,256,980 |
) |
(14,847,702 |
) |
17.9 |
% |
EPS for Class A ordinary shares |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
For the three months ended March 31, 2021 |
||||||||||||
Weighted average shares outstanding |
39,581,933 | 13,413,900 | 52,995,833 | |||||||||
Basic and diluted loss per ordinary share |
$ | — | $ | (0.22 | ) | $ | (0.22 | ) |
EPS for Class B ordinary shares |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
For the three months ended March 31, 2021 |
||||||||||||
Weighted average shares outstanding |
33,104,817 | (18,251,692 | ) | 14,853,125 | ||||||||
Basic and diluted loss per ordinary share |
$ | (0.38 | ) | $ | 0.16 | $ | (0.22 | ) |
* | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
Dated: March 14, 2022 | SVF INVESTMENT CORP. | |||||
By: | /s/ Rajeev Misra | |||||
Name: | Rajeev Misra | |||||
Title: | Chief Executive Officer |
1 Year SVF Investment Chart |
1 Month SVF Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions